Prescription Drug News and Research

RSS

National Rx Drug Abuse Summit to make impact on America's prescription drug problem

The prescription drug epidemic continues to take lives in America, causing 100 overdose deaths daily, according to the Centers for Disease Control and Prevention.

27 Mar 2013

Research indicates vitamin D can control blood-sugar levels in obese youths

Childhood and adolescent obesity rates in the United States have increased dramatically in the past three decades. Being obese puts individuals at greater risk for developing Type 2 diabetes, a disease in which individuals have too much sugar in their blood.

27 Mar 2013

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of Crestor tablets, as well as Actavis' rosuvastatin zinc alternate salt product.

25 Mar 2013

Roundup: Medicaid causes budget headache in Wash. state; Minn. plan to cut health services a surprise; Midwife access issues in N.C.

A selection of health policy stories from Washington state, Minnesota, North Carolina, Tennessee, Georgia, Arizona, California and Colorado.

22 Mar 2013

Viewpoints: Indian health hit by budget cuts; Health care doesn't work like normal markets; Gov. Rick Scott paying a price for Medicaid expansion

The Congressional Republicans who brought us the mindless budget cuts known as the sequester have shown remarkable indifference to life-sustaining government services, American jobs and other programs.

22 Mar 2013

First Edition: March 21, 2013

Today's headlines include various reports about what the public knows -- and doesn't know -- about the health law.

21 Mar 2013

Higher mortality rates among Americans younger than 50 linked to low life expectancy

Higher mortality rates among Americans younger than 50 are responsible for much of why life expectancy is lower in the United States than most of the world's most developed nations.

17 Mar 2013

Experts offer views on controlling health care costs

At two different forums, health care policy experts talk about changes in policy that might slow health spending.

15 Mar 2013

Physician gender has no impact on patients’ healthcare costs or mortality

Female doctors' patients do not use health-care services more or die less frequently than patients treated by male doctors, a prospective, observational study by researchers at UC Davis Health System has found.

14 Mar 2013

Eplerenone may also reduce risk of heart failure, shows REMINDER trial

The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

Roundup: N.Y. psychiatrists sue insurer over parity; Calif. lawmakers hear from families of prescription drug victims

News outlets cover health care developments in California, Georgia, Iowa, Kansas, Maine, Missouri and New York.

13 Mar 2013

FDA accepts AMAG’s Feraheme sNDA for review

AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.

6 Mar 2013

Roundup: Mass. health costs may start accelerating again; Review questions Minn. HMO payment rates; Calif. lawmakers approve health care bills

After several years of moderating costs, there are signs the rate of increase in Massachusetts health care prices -- and insurance premiums -- may soon start accelerating again, exceeding a heralded cost cap set by the state last year.

5 Mar 2013

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

For the first time in more than 20 years, there was a decrease in 2012 U.S. spending on traditional prescription drugs — primarily pills people take to treat more common diseases such as high cholesterol and high blood pressure — according to new data released today by Express Scripts.

5 Mar 2013

Report: Drug companies spent $84M marketing pharmaceuticals in the District of Columbia in 2011

Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according to a report by researchers at the George Washington University School of Public Health and Health Services.

2 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

State roundup: Health care industry calls drug testing bill in N.H. 'vague'

Representatives from the health care industry said Tuesday they have a vested interest in stopping employees from stealing controlled substances but a bill being considered by New Hampshire lawmakers to drug test their workers is too vague. The proposal is part of the legislative response to a recent scandal at Exeter Hospital, where an employee allegedly stole drugs and replaced them with Hepatitis C infected syringes later used on patients.

28 Feb 2013

FSMB announces recipients of 2013 medical awards

The Federation of State Medical Boards (FSMB) announced the recipients of its 2013 awards recognizing outstanding service and leadership in the field of medical regulation.

28 Feb 2013

FDA accepts Antares Pharma's New Drug Application for OTREXUP

Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

27 Feb 2013

FDA's Oncologic Drugs Advisory Committee to review NDA for tivozanib

AVEO Oncology and Astellas Pharma Global Development, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee will review the company's New Drug Application for tivozanib for the treatment of patients with advanced renal cell carcinoma during the morning session of its meeting on May 2, 2013.

27 Feb 2013

Prescription Drug News and Research

National Rx Drug Abuse Summit to make impact on America's prescription drug problem

Research indicates vitamin D can control blood-sugar levels in obese youths

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

Roundup: Medicaid causes budget headache in Wash. state; Minn. plan to cut health services a surprise; Midwife access issues in N.C.

Viewpoints: Indian health hit by budget cuts; Health care doesn't work like normal markets; Gov. Rick Scott paying a price for Medicaid expansion

First Edition: March 21, 2013

Higher mortality rates among Americans younger than 50 linked to low life expectancy

Experts offer views on controlling health care costs

Physician gender has no impact on patients’ healthcare costs or mortality

Eplerenone may also reduce risk of heart failure, shows REMINDER trial

Roundup: N.Y. psychiatrists sue insurer over parity; Calif. lawmakers hear from families of prescription drug victims

FDA accepts AMAG’s Feraheme sNDA for review

Roundup: Mass. health costs may start accelerating again; Review questions Minn. HMO payment rates; Calif. lawmakers approve health care bills

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

Report: Drug companies spent $84M marketing pharmaceuticals in the District of Columbia in 2011

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

State roundup: Health care industry calls drug testing bill in N.H. 'vague'

FSMB announces recipients of 2013 medical awards

FDA accepts Antares Pharma's New Drug Application for OTREXUP

FDA's Oncologic Drugs Advisory Committee to review NDA for tivozanib

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News